25 May 2013
Keywords: orphan, medical, work, iv, busulfan, division, company
Article | 28 February 1994
The Orphan Medical division of US company Chronimed has acquired an
exclusive worldwide licensing agreement with the MD Anderson Cancer
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 February 1994
7 March 1994
24 May 2013
© 2013 thepharmaletter.com